374Water Inc. (SCWO): Nasdaq/NYSE listing notice — 374Water receives Nasdaq deficiency notice for bid price below $1; has until July 14, 2025 to comply
374Water Inc.
Received Nasdaq deficiency letter on Jan 15, 2025 for bid price below $1 for 30 consecutive days.
Compliance period ends July 14, 2025; must close at $1.00+ for 10 consecutive business days to cure.
If not compliant by deadline, Nasdaq may grant second 180-day period or begin delisting; company may appeal.
Company considering options including reverse stock split to regain compliance.
Also filed new investor presentation on January 22, 2025 (Exhibit 99.1).
374Water Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).
Exchange
nasdaq
Notice
deficiency notice
Deficiency
minimum bid price
Rules
5550(a)(2)
Exact text from the filing
January 15, 2025, 374Water Inc. (the “Company”) received a deficiency letter from the Nasdaq Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, for the l
374Water Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).
Exchange
nasdaq
Notice
deficiency notice
Deficiency
minimum bid price
Rules
5550(a)(2)
Exact text from the filing
January 15, 2025, 374Water Inc. (the “Company”) received a deficiency letter from the Nasdaq Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, for the last 30 consecutive business days, the closing bid price for the Company’s common stock has been below the minimum $1.00 per share required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”). The Nasdaq deficiency letter has no immediate effect on the listing of the Company’s common stock, and its c
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.